U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216131) titled 'A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years' on Oct. 10.

Brief Summary: The purpose of this study is to determine how the experimental medication AZD0780 impacts the pharmacokinetics (PK) of metformin, a common medication used to treat type 2 diabetes mellitus, when given together in healthy participants.

Study Start Date: Nov. 10

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AZD0780

AZD0780 will be administered orally.

DRUG: Metformin

Metformin will be administered orally.

Recruitment Status: NOT_YET_RECRUITING...